PlainBillCongress, translated.Legislation. Context. Public interest.Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S13583-13589)
Congressional Research Service
Version 00 · Introduced in Senate · Dec 14, 2005
American Center for Cures Act of 2005 - Amends the Public Health Service Act to establish within the National Institutes of Health (NIH) an American Center for Cures to promote translational research to speed the development of effective therapies, diagnostics, and cures.
Establishes a Cures Council to help advise and direct the Center's translational research efforts.
Authorizes the Center's Director (the Director of Cures) to establish Federally Funded Research and Development Centers to serve as research sites.
Showing the opening paragraphs of the official summary.
Establishes within the Center a Health Advanced Research Projects Agency to advance the development and deployment of critical health products. Authorizes the Agency to flexibly fund projects.
Requires the Director of Cures to establish a series of Centralized Institutional Review Boards to serve as human subject safety and well being custodians for multi-institutional clinical trials that are funded by public dollars.
Requires the Director of NIH to commission the Institute of Medicine to study the rules that protect patient safety and anonymity with respect to clinical research.
Establishes an Office of Bioscientific Enterprise Development (OBED) and transfers to it the Small Business Innovation Research and Small Business Technology Transfer programs. Requires OBED to partner grantees with potential purchasers of products.
Establishes an Office of Technology Transfer (OTT) and transfers to it appropriate NIH functions. Requires OTT to establish: (1) an Office of Rapid Access to Intervention Development to accelerate the process from laboratory to clinic; and (2) a program that cultivates industry interest in NIH-funded research.
Establishes an Office of Intramural Risk Opportunity and Mapping to oversee the intramural research programs of NIH.
Requires the Center for Biotechnology Information to develop new computational methods to aid in the processing of genomic data.
Provides for the construction of a clinical study registry and results database.
People & committees
Sen. Lieberman, Joseph I. [D-CT] · D–CT
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S13583-13589)
Sponsor introductory remarks on measure. (CR S13577-13583)
Introduced in Senate
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 15, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze S.2104 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine S.2104 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine S.2104 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine S.2104 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.